Buy 2 and save 9.41 USD / -18%
Mebucaine N contains the antiseptic active ingredient cetylpyridine chloride and the local analgesic active ingredient lidocaine hydrochloride.
Mebucaine N is used for the short-term symptomatic treatment of pain used for mild inflammation in the mouth and throat.
Note for diabetics: 1 Mebucaine N lozenge contains 1,107 g sorbitol, which is approximately 12 kJ (2.88 kcal).
Mebucaine N must not be used in case of hypersensitivity to cetylpyridine chloride, lidocaine hydrochloride, to other local anesthetics or to one of the excipients according to the composition.
Mebucaine N is not recommended for people under the age of 18 due to insufficient data on its use.
Mebucaine N should not be used on bleeding wounds in the mucous membrane, as the absorption of the active ingredients into the blood may be increased. This applies in particular to patients with cardiovascular diseases or a tendency to cramps.
Caution is required in patients with impaired liver and/or kidney function, as these limitations can lead to increased concentrations of the active substance in the blood.
Mebucaine N is intended for short-term use for a maximum of 3 consecutive days.
You should consult your doctor in the following cases:
Do not use Mebucaine N while or immediately before drinking or eating: the local anesthetic effect of lidocaine can cause a temporary numbness in the mouth and throat and make swallowing difficult .
Alcoholic beverages should be avoided, as alcohol increases the absorption of cetylpyridine chloride in the blood, which could lead to an overdose.
Mebucaine N should not be taken immediately before or after brushing your teeth may reduce the effectiveness of Mebucaine N.
1 lozenge of Mebucaine N contains 1,107 g of sorbitol (E420): sorbitol is a source of fructose. Talk to your doctor before using this medicine if your doctor has told you that you have an intolerance to some sugars or if you have hereditary fructose intolerance (HFI) - a rare inherited condition in which a person cannot break down fructose - was determined. Patients with hereditary fructose intolerance should not use this medicine.
Tell your doctor, pharmacist or druggist if you
Mebucaine N should not be used during pregnancy unless directed by a doctor.
The active ingredient lidocaine enters the human body in very small amounts breast milk over. Mebucaine N should not be used while breastfeeding.
Unless otherwise prescribed by the doctor:
Mebucainee N is intended for short-term use for a maximum of 3 consecutive days.
The lowest effective dose should always be used over the shortest possible treatment period.
The recommended dosage and application frequency must not are exceeded.
Do not use at the same time as other antiseptic (disinfecting) agents.
1 lozenge every 2 to 3 hours, up to 6 times a day , let it slowly melt in your mouth. Maximum daily dose: Do not exceed 6 lozenges within 24 hours.
Do not chew the lozenges or swallow them whole. Do not use while or immediately before drinking or eating (see «When should you be careful when using Mebucaine N?»).
If you experience severe pain, difficulty swallowing, increased salivation, fever or if after 3 -day treatment does not improve, a doctor should be consulted.
Taking a large Amount of Mebucaine N lozenges can cause nausea, vomiting, lowering of blood pressure, changes in heart rhythm, impaired breathing, seizures, coma, cardiac and respiratory arrest.
After ingestion of a large amount of Mebucaine N, immediate ingestion of milk or egg whites whipped in water. Consult a doctor immediately.
Mebucaine N is not recommended for people under the age of 18 because there is insufficient data on its use.
Stick to the dosage given in the package leaflet or prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.
Mebucaine N can cause side effects.
Rare (affects 1 to 10 users in 10,000): changes in taste, numbness of the tongue, nausea, irritation of the mouth and throat.
Very rare (affects less than 1 user in 10,000): skin rashes, hypersensitivity reactions.
See instructions under «How do you use Mebucaine N?»
If you notice any side effects, contact your doctor, pharmacist or druggist. This also applies in particular to side effects that are not listed in this leaflet.
The medicinal product may only be used up to the end of the period marked "EXP" on the container Date are used.
Store at 15-30°C. Keep in the original packaging.
Keep out of the reach of children.
Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed technical information.
1 lozenge Mebucaine N contains: cetylpyridine chloride 2 mg, lidocaine hydrochloride 1 mg
Acesulfame potassium, microcrystalline cellulose, citric acid monohydrate, macrogol 6000, magnesium stearate, corn starch, sorbitol (E420), peppermint oil and levomenthol.
1 Lozenges contain 1.107 g sorbitol, equivalent to 12 kJ (2.88 kcal).
66256 (Swissmedic).
In pharmacies and drugstores, without a doctor's prescription.
Packs of 20 and 30 lozenges.
Spirig HealthCare AG, 4622 Egerkingen
This leaflet was published in September 2020 last checked by the drug authority (Swissmedic).